Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
7,597,689
-
Total 13F shares
-
31,470
-
Share change
-
+23,986
-
Total reported value
-
$121,752
-
Price per share
-
$3.90
-
Number of holders
-
10
-
Value change
-
+$92,526
-
Number of buys
-
7
-
Number of sells
-
3
Institutional Holders of SRx Health Solutions, Inc. - Common Stock, $0.001 par value (SRXH) as of Q2 2024
As of 30 Jun 2024,
SRx Health Solutions, Inc. - Common Stock, $0.001 par value (SRXH) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,470 shares.
The largest 10 holders included
HRT FINANCIAL LP, CITADEL ADVISORS LLC, BROWN BROTHERS HARRIMAN & CO, Tower Research Capital LLC (TRC), UBS Group AG, Qube Research & Technologies Ltd, OSAIC HOLDINGS, INC., BlackRock Inc., BANK OF AMERICA CORP /DE/, and MORGAN STANLEY.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.